← Back to REPL

Replimune Group, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 14/08/2026Dec 2025Filed 03/02/2026Sep 2025Filed 03/02/2026Jun 2025Filed 14/08/2026Dec 2024Filed 03/02/2026Sep 2024Filed 03/02/2026Jun 2024Filed 03/02/2026Dec 2023Filed 12/02/2025
−$70−$71−$83−$87−$66−$53−$54−$51
−$0.72−$0.77−$0.90−$0.95−$0.79−$0.68−$0.78−$0.77
9792929283796967

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.